Alterola Biotech Inc. (ABTI) Announces Appointment of Mr. Guy Webber

Author's Avatar
Jan 03, 2022

BIRKENHEAD, UK / ACCESSWIRE / January 3, 2022 / The Board of Directors (the "Board") of Alterola Biotech Inc. (OTC PINK:ABTI) or (the "Company") is pleased to announce that Mr. Guy Webber ("Mr. Webber") has been appointed as a Preclinical Development Director of the Company as of February 01, 2022.